News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
788,378 Results
Type
Article (78664)
Company Profile (294)
Press Release (709420)
Section
Business (216876)
Career Advice (3522)
Deals (38101)
Drug Delivery (125)
Drug Development (89385)
Employer Resources (183)
FDA (17784)
Job Trends (16530)
News (374540)
Policy (37416)
Tag
Academia (2971)
Alliances (54905)
Alzheimer's disease (1426)
Approvals (17736)
Artificial intelligence (236)
Bankruptcy (372)
Best Places to Work (12469)
Biotechnology (199)
Breast cancer (245)
Cancer (1848)
Cardiovascular disease (148)
Career advice (2986)
CAR-T (139)
Cell therapy (403)
Clinical research (71474)
Collaboration (722)
Compensation (352)
COVID-19 (2824)
C-suite (175)
Data (1674)
Diabetes (232)
Diagnostics (6759)
Earnings (84278)
Employer resources (160)
Events (119996)
Executive appointments (601)
FDA (18739)
Funding (651)
Gene therapy (283)
GLP-1 (764)
Government (5029)
Healthcare (20559)
Infectious disease (2946)
Inflammatory bowel disease (134)
Interviews (668)
IPO (17297)
Job creations (4539)
Job search strategy (2477)
Layoffs (514)
Legal (9070)
Lung cancer (276)
Manufacturing (263)
Medical device (14208)
Medtech (14213)
Mergers & acquisitions (21194)
Metabolic disorders (624)
Neuroscience (1884)
NextGen: Class of 2025 (7370)
Non-profit (5052)
Northern California (2109)
Obesity (346)
Opinion (261)
Patents (172)
People (63077)
Phase I (22050)
Phase II (31123)
Phase III (23402)
Pipeline (743)
Postmarket research (3396)
Preclinical (9835)
Radiopharmaceuticals (263)
Rare diseases (362)
Real estate (6910)
Regulatory (25212)
Research institute (2633)
Resumes & cover letters (550)
Southern California (1836)
Startups (3929)
United States (19221)
Vaccines (716)
Weight loss (259)
Date
Today (10)
Last 7 days (642)
Last 30 days (2723)
Last 365 days (36348)
2025 (4792)
2024 (37142)
2023 (42001)
2022 (53298)
2021 (58163)
2020 (57157)
2019 (50809)
2018 (38701)
2017 (36054)
2016 (36420)
2015 (42560)
2014 (36805)
2013 (33295)
2012 (34904)
2011 (34939)
2010 (34738)
Location
Africa (1147)
Arizona (218)
Asia (46895)
Australia (8241)
California (4868)
Canada (1739)
China (419)
Colorado (224)
Connecticut (248)
Europe (108157)
Florida (700)
Georgia (175)
Illinois (525)
Indiana (270)
Maryland (779)
Massachusetts (3749)
Michigan (212)
Minnesota (353)
New Jersey (1404)
New York (1403)
North Carolina (942)
Northern California (2109)
Ohio (183)
Pennsylvania (1090)
South America (1506)
Southern California (1836)
Texas (725)
Utah (151)
Washington State (485)
788,378 Results for "european organization for research and treatment of cancer".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
News
HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
October 7, 2024
·
15 min read
Press Releases
NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment
January 24, 2025
·
4 min read
Press Releases
Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer
January 23, 2025
·
5 min read
Press Releases
European Commission approves LAZCLUZE®▼ (lazertinib) in combination with RYBREVANT®▼ (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
January 21, 2025
·
16 min read
Press Releases
ImmunityBio Announces European Medicines Agency Acceptance of Marketing Authorization Application for ANKTIVA® for the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
January 27, 2025
·
9 min read
Biotech Beach
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
World-renowned physicians and researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new data and offer expert perspectives on leading-edge cancer research and treatments in development at the 2024 ASCO Annual Meeting.
May 23, 2024
·
11 min read
Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Propanc Biopharma, Inc. today announced that a certificate of grant for the Company’s “composition of proenzymes for cancer treatment,” patent was received from the European Patent Office.
April 16, 2024
·
3 min read
Press Releases
European Commission approves RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
December 30, 2024
·
16 min read
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
1 of 78,838
Next
